An 11-Year, Single-institution Analysis of Intra-aortic Balloon Pump Use in Cardiac Surgery

Zaky, Sherif; Hanna, Amgad H.; Esa, Wael Ali Sakr; Xu, Meng; Lober, Cheryl; Sessler, Daniel I.; González-Stawinski, Gonzalo V.; Savage, Robert M.; Bashour, C. Allen

doi:10.1053/j.jvca.2008.12.027

Cited by 15 publications

(6 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…6,14,21,22 However, increased utilization rates were not consistent at every center. 23 While some studies have indicated an increase in the use of IABP during our study period, 24,25 we observed the contrary, which can in part be explained by smaller sample size and limited datasets previously reported in other studies. Also, patient selection based on procedure undertaken (high-risk PCI vs. all-comer PCI) and our study period spanning greater than a decade could have potentially contributed to the differences reported.…”

Section: Discussioncontrasting

confidence: 77%

Temporal trends in the use of intraaortic balloon pump associated with percutaneous coronary intervention in the United States, 1998-2008

Patel¹,

Shivaraju²,

Fonarow³

et al. 2014

American Heart Journal

View full text Add to dashboard Cite

Background With conflicting evidence regarding the usefulness of intra-aortic balloon pump (IABP), reports of IABP use in the United States (US) have been inconsistent. Our objective was to examine trends in IABP usage in percutaneous coronary intervention (PCI) in the US, and to evaluate the association of IABP use with mortality. Methods Retrospective, observational study using patient data obtained from the Nationwide Inpatient Sample (NIS) database from 1998 to 2008. Patients undergoing any PCI (1,552,602 procedures) for a primary diagnosis of symptomatic coronary artery disease (CAD) and acute coronary syndrome (ACS), including non-ST elevation MI (NSTEMI) and ST elevation MI (STEMI), were evaluated. Results The overall use of IABP significantly decreased during the study period from 0.99% in 1998 to 0.36% in 2008 (univariate and multivariate p for trend <.0001). Patients who received IABP had substantially higher rates of shock compared to those who did not receive IABP (38.09% vs. 0.70%, p<.0001), which was associated with markedly higher in-hospital mortality rates (20.31% vs. 0.72%, p<.0001). However, IABP use significantly decreased in patients with shock (36.5% to 13.4%) and AMI (2.23% to 0.84%) (univariate and multivariate p for trend for both <.0001). A temporal reduction in all-cause PCI-associated mortality from 1.1% in 1998 to 0.86% in 2008 (univariate and multivariate p for trend <.0001) was also observed. Conclusions The utilization of IABP associated with PCI significantly decreased between 1998 and 2008 in the US, even amongst patients with acute myocardial infarction and shock.

show abstract

Section: Discussioncontrasting

confidence: 77%

Temporal trends in the use of intraaortic balloon pump associated with percutaneous coronary intervention in the United States, 1998-2008

Patel¹,

Shivaraju²,

Fonarow³

et al. 2014

American Heart Journal

View full text Add to dashboard Cite

show abstract

“…There is still no consensus on the ideal time of insertion since the preoperative (prophylactic) insertion of IABP in the high‐risk patients CABG was reported by many studies and the results showed that complications and mortality rate were similar with intraoperative IABP insertion 11,14–16 as in this novel study only including intraoperative IABP patients 17 . Despite the existing information, the proper use of ventricular support in CABG is still controversial.…”

mentioning

confidence: 71%

Use of intra‐aortic balloon pump during coronary artery bypass graft surgery. Current questions and few answers

Escutia-Cuevas

2021

J Card Surg

View full text Add to dashboard Cite

“…Several studies have been reported that the in‐hospital mortality rate after IABP insertion is 7%–50.6% and it depends on the type of heart operation 3–5,7,10–12,15,18,19 . The patients who underwent heart valve surgery the hospital mortality higher compared to the patients who underwent CABG 4,11 .…”

Section: Discussionmentioning

confidence: 99%

“…Although the new circulatory assist devices were used for circulatory support of patients with acute heart disease, including cardiac surgery patients, benefits of IABP compared with other assistive devices for the management of preoperative or intraoperative low cardiac output syndrome in cardiac surgery is controversial 8 . Preoperative (prophylactic) insertion of IABP in the high‐risk patients due to preoperative acute coronary syndrome (ACS) or unstable CAD patients was reported by many studies and the results showed that complications and mortality rate was similar with intraoperative IABP insertion 9–12 . Addition risk factors have been raised in cardiac surgery patients in the last years and these are advanced age, much major chronic comorbidity, and more patients with poor left ventricle function and end‐stage ischemic heart disease.…”

Section: Introductionmentioning

confidence: 99%

Analysis of risk factors for in‐hospital mortality in 177 patients who underwent isolated coronary bypass grafting and received intra aortic balloon pump

et al. 2021

View full text Add to dashboard Cite

Background and Aim of the Study Intra‐aortic balloon pump (IABP) is the most commonly used device for circulatory support of patients with heart disease. The aim of this study evaluated the risk factors for outcomes of patients who underwent isolated coronary bypass grafting and received IABP. Methods One hundred‐seventy‐seven patients underwent isolated coronary bypass grafting and received intraoperative IABP. All perioperative data were recorded. The primary end‐point was in‐hospital mortality, while the secondary end‐points were the length of intensive care unit (ICU) stay and hospital length of stay (LOS). Results In‐hospital mortality was 5.6% (10 patients). Multivariable logistic regression analysis showed that the risk factors for in‐hospital mortality were preoperative plasma creatinine level and cardiopulmonary bypass (CPB) time (for both p < .05). Multivariable linear regression analysis showed that postoperative acute kidney injury (AKI), immediate plasma troponin after operation, numbers of grafts, and CPB time were predicted the hospital LOS, while postoperative AKI, preoperative left ventricular ejection fraction, and immediate plasma troponin after operation were predicted the lengths of ICU stay. Conclusion Our analysis showed that increased preoperative plasma creatinine, postoperative renal dysfunction, and CPB time negatively affected the outcomes of patients who received intraoperative IABP insertion.

show abstract

An 11-Year, Single-institution Analysis of Intra-aortic Balloon Pump Use in Cardiac Surgery

Cited by 15 publications

References 24 publications

Temporal trends in the use of intraaortic balloon pump associated with percutaneous coronary intervention in the United States, 1998-2008

Temporal trends in the use of intraaortic balloon pump associated with percutaneous coronary intervention in the United States, 1998-2008

Use of intra‐aortic balloon pump during coronary artery bypass graft surgery. Current questions and few answers

Analysis of risk factors for in‐hospital mortality in 177 patients who underwent isolated coronary bypass grafting and received intra aortic balloon pump

Contact Info

Product

Resources

About